1. Home
  2. BGC vs CAI Comparison

BGC vs CAI Comparison

Compare BGC & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGC Group Inc.

BGC

BGC Group Inc.

HOLD

Current Price

$12.14

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Logo Caris Life Sciences Inc.

CAI

Caris Life Sciences Inc.

HOLD

Current Price

$24.46

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGC
CAI
Founded
1945
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
6.2B
IPO Year
1999
2025

Fundamental Metrics

Financial Performance
Metric
BGC
CAI
Price
$12.14
$24.46
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$30.91
AVG Volume (30 Days)
2.5M
4.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
0.72%
N/A
EPS Growth
24.00
69.79
EPS
0.31
N/A
Revenue
$2,941,460,000.00
$812,033,000.00
Revenue This Year
$22.26
$25.24
Revenue Next Year
$7.03
$22.32
P/E Ratio
$39.32
N/A
Revenue Growth
29.99
96.97
52 Week Low
$8.27
$14.19
52 Week High
$12.89
$34.54

Technical Indicators

Market Signals
Indicator
BGC
CAI
Relative Strength Index (RSI) 61.79 53.42
Support Level $11.59 $17.15
Resistance Level $12.35 $28.88
Average True Range (ATR) 0.37 1.36
MACD 0.04 -0.44
Stochastic Oscillator 89.34 12.21

Price Performance

Historical Comparison
BGC
CAI

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, the Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

About CAI Caris Life Sciences Inc.

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Share on Social Networks: